Rezultati - Tibor Kovacsovics

Refine Results
  1. 1
    Antibody-independent activation of C1, the first component of complement, by cardiolipin.

    Antibody-independent activation of C1, the first component of complement, by cardiolipin. od Tibor Kovacsovics, J Tschopp, A Kress, H. Isliker

    Izdano 1985
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    D3 Phosphoinositides and Outside-in integrin Signaling by Glycoprotein IIb-IIIa Mediate Platelet Actin Assembly and Filopodial Extension Induced by Phorbol 12-Myristate 13-Acetate

    D3 Phosphoinositides and Outside-in integrin Signaling by Glycoprotein IIb-IIIa Mediate Platelet Actin Assembly and Filopodial Extension Induced by Phorbol 12-Myristate 13-Acetate od John H. Hartwig, Sophia Kung, Tibor Kovacsovics, Paul A. Janmey, Lewis C. Cantley, Thomas P. Stossel, Alex Toker

    Izdano 1996
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients

    Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients od Sara Yousef, James Marvin, Mary Steinbach, Amanda Langemo, Tibor Kovacsovics, Mascha Binder, Nicolaus Kröger, Tim Luetkens, Djordje Atanackovic

    Izdano 2015
    Polni tekst Polni tekst
    Carta
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Phosphoinositide 3-Kinase Inhibition Spares Actin Assembly in Activating Platelets but Reverses Platelet Aggregation

    Phosphoinositide 3-Kinase Inhibition Spares Actin Assembly in Activating Platelets but Reverses Platelet Aggregation od Tibor Kovacsovics, Christilla Bachelot‐Loza, Alex Toke, Chris J. Vlahos, Brian Duckworth, Lewis C. Cantley, John H. Hartwig

    Izdano 1995
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

    FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia od Elie Traer, Jacqueline Martinez, Nathalie Javidi‐Sharifi, Anupriya Agarwal, Jennifer Dunlap, Isabel English, Tibor Kovacsovics, Jeffrey W. Tyner, Melissa H. Wong, Brian J. Druker

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    RNAi screen for rapid therapeutic target identification in leukemia patients

    RNAi screen for rapid therapeutic target identification in leukemia patients od Jeffrey W. Tyner, Michael W. Deininger, Marc Loriaux, Bill H. Chang, Jason Gotlib, Stephanie G. Willis, Heidi S. Erickson, Tibor Kovacsovics, Thomas O’Hare, Michael C. Heinrich, Brian J. Druker

    Izdano 2009
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    The genetic landscape of germline<i>DDX41</i>variants predisposing to myeloid neoplasms

    The genetic landscape of germline<i>DDX41</i>variants predisposing to myeloid neoplasms od Peng Li, Sara Brown, Margaret S. Williams, Thomas A. White, Wei Xie, Wei Cui, Deniz Peker, Li Lei, Christian A. Kunder, Huan‐You Wang, Sarah Murray, Jennie Vagher, Tibor Kovacsovics, Jay Patel

    Izdano 2022
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML

    Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML od Jeffrey E. Lancet, Jorge E. Cortés, Donna E. Hogge, Martin S. Tallman, Tibor Kovacsovics, Lloyd E. Damon, Rami S. Komrokji, Scott R. Solomon, Jonathan E. Kolitz, Maureen Cooper, Andrew M. Yeager, Arthur C. Louie, Eric J. Feldman

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia

    Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia od Bob Löwenberg, Wim van Putten, Matthias Theobald, J Gmür, Leo F. Verdonck, Pieter Sonneveld, Martin F. Fey, Harry C. Schouten, Georgine de Greef, Augustin Ferrant, Tibor Kovacsovics, Aloïs Gratwohl, Simon Daenen, Peter C. Huijgens, Marc Boogaerts

    Izdano 2003
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia

    Combination of the low anticoagulant heparin CX-01 with chemotherapy for the treatment of acute myeloid leukemia od Tibor Kovacsovics, Alice S. Mims, Mohamed E. Salama, Jeremy Pantin, Narayanam V. Rao, Ken M. Kosak, Peter Ahorukomeye, Martha Glenn, Michael W. Deininger, Kenneth M. Boucher, Linda M. Bavisotto, Gerardo Gutiérrez‐Sánchez, Thomas P. Kennedy, Stephen Marcus, Paul J. Shami

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Functional integration of acute myeloid leukemia into the vascular niche

    Functional integration of acute myeloid leukemia into the vascular niche od Christopher R. Cogle, D C Goldman, Gerard J. Madlambayan, Ronald P. Leon, Azzah Al Masri, Helen Clark, Steven A. Asbaghi, Jeffrey W. Tyner, Jennifer Dunlap, Gaofeng Fan, Tibor Kovacsovics, Qianshi Liu, Amy Meacham, Kimberly L. Hamlin, Robert Hromas, Edward W. Scott, Will Fleming

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial

    Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial od Xavier Thomas, Jean-Michel Boiron, Françoise Huguet, Hervé Dombret, Ken Bradstock, Norbert Vey, Tibor Kovacsovics, André Delannoy, Nathalie Fegueux, Pierre Fenaux, Aspasia Stamatoullas, Jean-Paul Vernant, Olivier Tournilhac, Agnès Buzyn, Oumédaly Reman, C Charrin, Claude Boucheix, Jean Gabert, Véronique Lhéritier, D Fière

    Izdano 2004
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma od Luciano J. Costa, Faith E. Davies, Gregory Monohan, Tibor Kovacsovics, Nicholas Burwick, Andrzej Jakubowiak, Jonathan L. Kaufman, Wan‐Jen Hong, Monique Dail, Ahmed Hamed Salem, Xiaoqing Yang, Abdullah Al Masud, Wijith Munasinghe, Jeremy A. Ross, Orlando F. Bueno, Shaji Kumar, Edward A. Stadtmauer

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial

    Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a... od T. de Witte, A Hagemeijer, Stefan Suciu, Amine Belhabri, Michel Delforge, Guido Kobbe, D. Selleslag, Harry C. Schouten, Augustin Ferrant, Harald Biersack, Sergio Amadori, Petra Muus, Joop H. Jansen, Eva Hellström‐Lindberg, Tibor Kovacsovics, P. W. Wijermans, GJ Ossenkoppele, Aloïs Gratwohl, J. P. Marie, R Willemze

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML

    A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML od Amir T. Fathi, Harry P. Erba, Jeffrey E. Lancet, Eytan M. Stein, Farhad Ravandi, Stefan Faderl, Roland B. Walter, Anjali S. Advani, Daniel J. DeAngelo, Tibor Kovacsovics, Anand Jillella, Dale L. Bixby, Moshe Levy, Megan M. O’Meara, Phoenix A. Ho, Jenna L. Voellinger, Anthony S. Stein

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia

    A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia od Eytan M. Stein, Roland B. Walter, Harry P. Erba, Amir T. Fathi, Anjali S. Advani, Jeffrey E. Lancet, Farhad Ravandi, Tibor Kovacsovics, Daniel J. DeAngelo, Dale L. Bixby, Stefan Faderl, Anand P. Jillella, Phoenix A. Ho, Megan M. O’Meara, Baiteng Zhao, Charles Biddle-Snead, Anthony S. Stein

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA

    Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA od Giovanni Palladini, Efstathios Kastritis, Mathew S. Maurer, Jeffrey A. Zonder, Monique C. Minnema, Ashutosh Wechalekar, Arnaud Jaccard, Hans C. Lee, Naresh Bumma, Jonathan L. Kaufman, Eva Medvedova, Tibor Kovacsovics, Michael Rosenzweig, Vaishali Sanchorawala, Xiang Qin, Sandra Y. Vasey, Brendan M. Weiss, Jessica Vermeulen, Giampaolo Merlini, Raymond L. Comenzo

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

    Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies od Eneida R. Nemecek, Katherine A. Guthrie, Mohamed L. Sorror, Brent L. Wood, K Doney, Ralf A. Hilger, Bart L. Scott, Tibor Kovacsovics, Richard T. Maziarz, Ann E. Woolfrey, Antonio Bedalov, Jean E. Sanders, John M. Pagel, Eileen Sickle, Robert P. Witherspoon, Mary E.D. Flowers, Frederick R. Appelbaum, H. Joachim Deeg

    Izdano 2010
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

    Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial od Stefan Faderl, Meir Wetzler, David A. Rizzieri, Gary J. Schiller, Madan Jagasia, Robert K. Stuart, Siddhartha Ganguly, David Avigan, Michael Craig, Robert H. Collins, Michael B. Maris, Tibor Kovacsovics, Stuart L. Goldberg, Karen Seiter, Parameswaran Hari, Jochen Greiner, Norbert Vey, Christian Récher, Farhad Ravandi, Eunice S. Wang, Michael J. Vasconcelles, Dirk Huebner, Hagop M. Kantarjian

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening

    Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening od Jeffrey W. Tyner, Wayne F. Yang, Armand Bankhead, Guang Fan, Luke B. Fletcher, Jade Bryant, Jason Glover, Bill H. Chang, Stephen E. Spurgeon, William H. Fleming, Tibor Kovacsovics, Jason Gotlib, Stephen T. Oh, Michael W. Deininger, C. Michel Zwaan, Monique L. den Boer, Marry M. van den Heuvel‐Eibrink, Thomas O’Hare, Brian J. Druker, Marc Loriaux

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: